10 Best Psychedelic Stocks to Buy According to Hedge Funds
In this article, we discuss 10 best psychedelic stocks to buy according to hedge funds.
Source: insidermonkey.com
📰 Expanded Access Program News
Page 10 - Expanded Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Expanded Access Program. Real-time updates on events, politics, business and more.
RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced agreement, with a...
Source: prnewswire.com
Mesoblast Limited (NASDAQ:MESO) Q2 2023 Earnings Call Transcript
Silviu Itescu: Thank you very much, operator. Good afternoon, good morning to everybody.
Source: insidermonkey.com
RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program
The National Institutes of Healths (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical...
United Kingdom Dror Ben Asher Redhill Biopharma Adi Frish Nuclear Countermeasures Program National Institute Of Allergy
Source: prnewswire.com
Investegate |RedHill Biopharma Announcements | RedHill Biopharma: RDHL Opaganib Selected by NIH RNCP For Development
Investegate announcements from RedHill Biopharma, RDHL Opaganib Selected by NIH RNCP For Development
United Kingdom Dror Ben Asher Redhill Biopharma Adi Frish Nuclear Countermeasures Program National Institute Of Allergy
Source: investegate.co.uk
Investegate |RedHill Biopharma Announcements | RedHill Biopharma: RedHill's RHB-102 Positive MHRA Meeting & MAA Plan
Investegate announcements from RedHill Biopharma, RedHills RHB-102 Positive MHRA Meeting & MAA Plan
Source: investegate.co.uk
BioVentrix® Names Dr. Ori Ben-Yehuda as Chief Medical Officer
/PRNewswire/ -- BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated...
Source: prnewswire.com
RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease
RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease - read this article along with other careers information, tips and advice on BioSpace
United States Foster Rosenblatt Daniellet Abramson Redhill Biopharma Adi Frish Redhill Biopharma Ltd
Source: biospace.com
FDA Agrees to Expanded Access Program for the BioVentrix® Revivent TC® System for the Treatment of Ischemic Heart Failure
/PRNewswire/ -- BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated...
Source: prnewswire.com
Mirati announces Adagrasib (KRAZATI™) Receives Breakthrough Therapy Designation from FDA for Patients with Advanced, KRAS-Mutated Colorectal Cancer and NEJM Publishes Phase 1b/2 Data from Adagrasib With or Without Cetuximab in Colorectal Cancer
U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for adagrasib in combination with cetuximab in patients with KRASG12C-mutated advanced colorectal cancer whose... | December 21, 2022
Alan Sandler Rona Yaeger Prnewswire Mirati Therapeutics Inc Drug Administration Mirati Therapeutics Inc Exchange Commission
Source: marketscreener.com